日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

肠道菌群改变介导的炎症促进肺癌发展和免疫抑制的肿瘤微环境

Zahraa Rahal # ,Yuejiang Liu # ,Fuduan Peng ,Sujuan Yang ,Mohamed A Jamal ,Manvi Sharma ,Hannah Moreno ,Ashish V Damania ,Matthew C Wong ,Matthew C Ross ,Ansam Sinjab ,Tieling Zhou ,Minyue Chen ,Inti Tarifa Reischle ,Jiping Feng ,Chidera Chukwuocha ,Elizabeth Tang ,Camille Abaya ,Jamie K Lim ,Cheuk Hong Leung ,Heather Y Lin ,Nathaniel Deboever ,Jack J Lee ,Boris Sepesi ,Don L Gibbons ,Jennifer A Wargo ,Junya Fujimoto ,Linghua Wang ,Joseph F Petrosino ,Nadim J Ajami ,Robert R Jenq ,Seyed Javad Moghaddam # ,Tina Cascone # ,Kristi Hoffman # ,Humam Kadara

Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases

以 IL-11R/EZH2 信号轴为靶点治疗骨肉瘤肺转移

Eswaran Devarajan, R Eric Davis, Hannah C Beird, Wei-Lien Wang, V Behrana Jensen, Arumugam Jayakumar, Cheuk Hong Leung, Heather Y Lin, Chia-Chin Wu, Stephanie A Ihezie, Jen-Wei Tsai, P Andrew Futreal, Valerae O Lewis

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

新辅助化疗联合纳武利尤单抗(加或不加伊匹木单抗)治疗可手术切除的非小细胞肺癌:NEOSTAR II期平台试验

Tina Cascone ,Cheuk H Leung ,Annikka Weissferdt ,Apar Pataer ,Brett W Carter ,Myrna C B Godoy ,Hope Feldman ,William N William Jr ,Yuanxin Xi ,Sreyashi Basu ,Jing Jing Sun ,Shalini S Yadav ,Frank R Rojas Alvarez ,Younghee Lee ,Aditya K Mishra ,Lili Chen ,Monika Pradhan ,Haiping Guo ,Ansam Sinjab ,Nicolas Zhou ,Marcelo V Negrao ,Xiuning Le ,Carl M Gay ,Anne S Tsao ,Lauren Averett Byers ,Mehmet Altan ,Bonnie S Glisson ,Frank V Fossella ,Yasir Y Elamin ,George Blumenschein Jr ,Jianjun Zhang ,Ferdinandos Skoulidis ,Jia Wu ,Reza J Mehran ,David C Rice ,Garrett L Walsh ,Wayne L Hofstetter ,Ravi Rajaram ,Mara B Antonoff ,Junya Fujimoto ,Luisa M Solis ,Edwin R Parra ,Cara Haymaker ,Ignacio I Wistuba ,Stephen G Swisher ,Ara A Vaporciyan ,Heather Y Lin ,Jing Wang ,Don L Gibbons ,J Jack Lee ,Nadim J Ajami ,Jennifer A Wargo ,James P Allison ,Padmanee Sharma ,Humam Kadara ,John V Heymach # ,Boris Sepesi #

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

可手术非小细胞肺癌新辅助治疗:纳武利尤单抗或纳武利尤单抗联合伊匹木单抗:NEOSTAR II期随机试验

Tina Cascone ,William N William Jr ,Annikka Weissferdt ,Cheuk H Leung ,Heather Y Lin ,Apar Pataer ,Myrna C B Godoy ,Brett W Carter ,Lorenzo Federico ,Alexandre Reuben ,Md Abdul Wadud Khan ,Hitoshi Dejima ,Alejandro Francisco-Cruz ,Edwin R Parra ,Luisa M Solis ,Junya Fujimoto ,Hai T Tran ,Neda Kalhor ,Frank V Fossella ,Frank E Mott ,Anne S Tsao ,George Blumenschein Jr ,Xiuning Le ,Jianjun Zhang ,Ferdinandos Skoulidis ,Jonathan M Kurie ,Mehmet Altan ,Charles Lu ,Bonnie S Glisson ,Lauren Averett Byers ,Yasir Y Elamin ,Reza J Mehran ,David C Rice ,Garrett L Walsh ,Wayne L Hofstetter ,Jack A Roth ,Mara B Antonoff ,Humam Kadara ,Cara Haymaker ,Chantale Bernatchez ,Nadim J Ajami ,Robert R Jenq ,Padmanee Sharma ,James P Allison ,Andrew Futreal ,Jennifer A Wargo ,Ignacio I Wistuba ,Stephen G Swisher ,J Jack Lee ,Don L Gibbons ,Ara A Vaporciyan ,John V Heymach # ,Boris Sepesi #

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

非小细胞肺癌新辅助免疫检查点抑制剂治疗后淋巴结免疫爆发模拟淋巴结疾病进展

Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, William N William Jr, Cheuk H Leung, Heather Y Lin, Sreyashi Basu, Shalini S Yadav, Apar Pataer, Kyle G Mitchell, Md Abdul Wadud Khan, Yushu Shi, Cara Haymaker, Luisa M Solis, Edwin R Parra, Humam Kadara, Ignacio I Wistuba, Padmanee Sharma, James P

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics

用于递送合成 RNAi 疗法的阳离子液晶纳米粒子

Emanuela Gentile, Taro Oba, Jing Lin, Ruping Shao, Feng Meng, Xiaobo Cao, Heather Y Lin, Majidi Mourad, Apar Pataer, Veerabhadran Baladandayuthapani, Dong Cai, Jack A Roth, Lin Ji

Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations

肺癌中 MEK-ERK 或 PI3K-AKT 信号对 EZH2 表达的调节受不同 KRAS 致癌基因突变的影响

Erick Riquelme, Carmen Behrens, Heather Y Lin, George Simon, Vassiliki Papadimitrakopoulou, Julie Izzo, Cesar Moran, Neda Kalhor, J Jack Lee, John D Minna, Ignacio I Wistuba

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia

使用福斯塔替尼靶向脾脏酪氨酸激酶作为对抗瓦尔登斯特伦巨球蛋白血症的策略

Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y Lin, Sheeba K Thomas, Chad C Bjorklund, Donna M Weber, Michael Wang, Jatin J Shah, Xing-Ding Zhang, Richard J Jones, Stephen M Ansell, Guang Yang, Steven P Treon, Robert Z Orlowski

Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma

C-MYC 与 PVT1 致癌基因频繁共扩增和协同作用促进恶性胸膜间皮瘤

Erick Riquelme, Milind B Suraokar, Jaime Rodriguez, Barbara Mino, Heather Y Lin, David C Rice, Anne Tsao, Ignacio I Wistuba

VEGF/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy

VEGF/VEGFR-2 上调肺腺癌细胞中的 EZH2 表达,EZH2 耗竭增强对铂类和 VEGFR-2 靶向治疗的反应

Erick Riquelme, Milind Suraokar, Carmen Behrens, Heather Y Lin, Luc Girard, Monique B Nilsson, George Simon, Jing Wang, Kevin R Coombes, J Jack Lee, Waun Ki Hong, John Heymach, John D Minna, Ignacio I Wistuba